Cobra Biomanufacturing recommends that its shareholders accept the offer from Recipharm to acquire the outstanding shares. The company said it no longer has sufficient working capital to continue and that its current financing facility runs out in January 2010.
Cobra
Sunday 27 December 2009
Cobra recommends Recipharm offer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment